Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Two urologists win first Verathon Technology Challenge

Verathon : 22 May, 2007  (New Product)
Verathon has announced the winners of the first annual Verathon Technology Challenge that focused on the field of urology
Subbarao V Yalla, MD and Maryrose Sullivan, PhD, both from the VA Boston Healthcare System and Harvard University are to receive the Verathon Technology Challenge Award, along with a check for $10,000 for their paper entitled 'Non-invasive Objective Assessment of Lower Urinary Tract Dysfunction: Differentiation of Overactive Bladder and Bladder Outlet Obstruction'.

In January of this year Verathon offered $10,000 for the most practical and scientifically valid protocol to study the relationship of bladder wall mass and OAB (overactive bladder) or BPH (benign prostatic hypertrophy) in men.

The goal was to determine how bladder wall mass (also known as UEBW or Ultrasound estimated bladder weight) measurements could best be utilized in clinical practice.

Abstracts, due 1 May 2007, needed to present a protocol and explain how that protocol would:

a) definitively refine the diagnostic impact of UEBW.

b) effectively demonstrate the clinical significance of the correlation between UEBW and bladder outlet obstruction (BOO), and how it would be implemented in a clinical trial.

The clinical significance of bladder wall mass in BOO and OAB has been noted, but to date it has not been well defined.

Measurement of bladder wall mass (UEBW) has the potential to provide physicians with useful information for determining patient care plans.

Verathon developed an innovative, handheld Ultrasound device, the BladderScan BVM 6500 that measures both bladder volume and bladder wall mass (UEBW) noninvasively.

The BVM 6500 was designed to assist in diagnosis of bladder hypertrophy secondary to obstruction, predicated on a correlation between UEBW and bladder outlet obstruction (BOO).

The goal of the challenge was to maximize the clinical utility and significance of the BladderScan BVM 6500 as a diagnostic and treatment tool.

'We received some excellent abstracts from North America, Europe and Asia', said Gerald McMorrow, CEO, founder and chairman of Verathon.

'We choose Yalla and Sullivan's study because we liked that they are looking to address the root cause of OAB through the combination of UEBW and other noninvasive measures as the outcome of the study; by using objective factors establishing the utility of UEBW'.

McMorrow continued, 'Their study proposal seems to result in the most pragmatic guide for diagnosis of either DO (detrusor overactivity) or BOO that could be performed by any frontline care provider (be it a Primary Care Physician or Urologist) and thereby lead to potentially improved treatment for the patient'.

'We're delighted to have won the Verathon Technology Challenge', stated Dr Subbarao Yalla, Professor of Surgery (Urology) at Harvard Medical School and practicing Urologist at VA Boston Healthcare System, an affiliate of Brigham and Women's Hospital and Harvard Medical School.

'Dr Sullivan and I have focused our careers on helping veterans who are afflicted with varied types of voiding dysfunction', stated Dr Yalla.

'While we teach and also supervise Urology residents, we have concentrated our efforts on research of lower urinary tract physiology.

'We're ready to begin this clinical study to learn more about how bladder wall mass measurements can assist in the diagnosis of overactive bladder and bladder outlet obstruction'.

The Verathon Technology challenge was open to anyone and international entries were permitted.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo